I have enjoyed working with Don on various projects through the years and know that his addition to the board adds both breadth and depth to our reach in the electrophysiology market.
New Haven, Conn. (PRWEB) May 11, 2015
EpiEP Inc. (EpiEP), a medical device company that has developed an FDA-cleared and CE-marked epicardial access system, today announced that Don Crawford, president and chief executive officer of Analytics For Life (A4L), has joined the EpiEP, Inc. board of directors.
Crawford has been a thought leader in the medical device field for more than 30 years focusing primarily on Cardiac Rhythm Management (CRM) products for electrophysiologists.
In his board role, he will participate in meetings with EpiEP, Inc. at the upcoming Heart Rhythm Society meeting in Boston, Mass., as EpiEP’s results from its EASe study will be presented in a moderated poster presentation on Friday, May 15, at 3:25 p.m.
“We are excited to add Don to our board as his vast experience lends additional expertise to the already diverse background of the EpiEP, Inc. board of directors and management,” said Pamela Bunes, chief executive officer and founder of EpiEP, Inc. “I have enjoyed working with Don on various projects through the years and know that his addition to the board adds both breadth and depth to our reach in the electrophysiology market.”
Crawford’s most recent executive management role as CEO and founder of Sapheon, Inc., which resulted in a successful exit to Covidien, Inc. and was acquired by Medtronic, Inc. in 2014 as part of its acquisition of Covidien. This transaction resulted in a total exit value of $238 million paid to its investors and shareholders. Prior to his role at Sapheon, Crawford represented Japan’s Lifeline interests in negotiating an asset purchase of Sorin Japan and a 10-year, $1 billion distribution contract agreement with Sorin CRM product lines.
Leading up to this international role with Lifeline, Crawford served as the general manager and member of the board of directors of Intermedics Japan K.K., which is now part of Boston Scientific, Inc.
“I am thrilled to give my support to the great foundation of success that has been achieved here at EpiEP,” said Crawford.
About EpiEP Inc
EpiEP, Inc. has licensed a portfolio of patent-protected epicardial medical devices from the University of Virginia. These products will impact the growing field of electrophysiology by providing physicians with novel tools to access and treat various cardiac conditions. The EpiAccess™ system is the flagship product, which provides electrophysiologists with a pressure guided access needle so the physician knows where the tip of the needle is located when it is being advanced to the virtual space between the pericardial sac and the surface of the heart without injuring the heart. The EpiAccess™ system is designed to result in better patient outcomes by reducing unintended puncture in the heart muscle. The system provides real-time feedback for physicians so they can know when the needle has reached the desired location.
Source: EpiEP, Inc.
Founder and CEO
+1 864 423 2526
+1 203 779 5383